Squarepoint
RMD icon

Squarepoint’s ResMed RMD Stock Holding History

Squarepoint’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-900
Closed -$232K – 4897
2025
Q2 		$232K Buy
+900
New +$215K ﹤0.01% 3880
2025
Q1 		– Sell
-1,900
Closed -$435K – 5272
2024
Q4 		$435K Sell
1,900
-2,500
-57% -$602K ﹤0.01% 3844
2024
Q3 		$1.07M Buy
+4,400
New +$983K ﹤0.01% 2553
2024
Q1 		– Sell
-7,900
Closed -$1.36M – 4522
2023
Q4 		$1.36M Buy
+7,900
New +$1.21M ﹤0.01% 2293

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Squarepoint's RMD Position: Q2 2026 in Review

Squarepoint increased its ResMed (RMD) stake by 553% in Q2 2026, buying an estimated $4.44M and bringing the position to 25,280 shares worth $4.93M. The position accounts for 0.01% of the portfolio, ranked #1610.

Squarepoint first reported a position in RMD in Q4 2015 and has held it in 31 quarters since. The position peaked at $141M in Q2 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Squarepoint held 25,280 shares of ResMed worth $4.93M as of Q2 2026.
  • Squarepoint bought 21,408 ResMed shares in Q2 2026, an estimated $4.44M.
  • ResMed made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1610 holding.
  • Squarepoint first reported a position in ResMed in Q4 2015 and has held it in 31 quarters since.
  • Squarepoint's ResMed position peaked at $141M in Q2 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.